The reasoning problem

Published 30 July 2026

Author(s): Stavroula Ntoufa

Spend enough time inside biopharmaceutical R&D and you notice that the decisions that matter most rarely happen during the documented steps; they happen in the pauses between them.

A senior scientist scans a body of literature and quietly sets aside ten supporting studies to focus on one contradictory finding nobody else flagged. A translational team halts a promising programme because a signal buried deep in the data introduces a level of uncertainty they're not willing to carry forward. An experienced researcher looks at a target that checks every box on paper and decides the underlying evidence isn't mature enough to justify moving forward. It might take another eighteen months before that changes.